MedPath

UNIVERSITY OF WASHINGTON

UNIVERSITY OF WASHINGTON logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private
Established
1861-01-01
Employees
10K
Market Cap
-
Website
https://www.cs.washington.edu

IMAGINE: Pilot Trial of a Digital Group Intervention to Prevent Perinatal Depression

Not Applicable
Not yet recruiting
Conditions
Depression During Pregnancy
Depression, Postpartum
First Posted Date
2024-12-24
Last Posted Date
2024-12-24
Lead Sponsor
University of Washington
Target Recruit Count
100
Registration Number
NCT06746337

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

Phase 2
Not yet recruiting
Conditions
Advanced Hodgkin Lymphoma
Classic Hodgkin Lymphoma
Lugano Classification Stage III Hodgkin Lymphoma AJCC v8
Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
Interventions
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Drug: Dacarbazine
Drug: Doxorubicin
Procedure: Echocardiography
Procedure: Multigated Acquisition Scan
Biological: Nivolumab
Procedure: Positron Emission Tomography
Drug: Vinblastine
Other: Questionnaire
First Posted Date
2024-12-20
Last Posted Date
2024-12-20
Lead Sponsor
University of Washington
Target Recruit Count
125
Registration Number
NCT06745076
Locations
πŸ‡ΊπŸ‡Έ

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!

Not Applicable
Not yet recruiting
Conditions
HIV Antiretroviral Therapy (ART) Adherence
First Posted Date
2024-12-20
Last Posted Date
2024-12-20
Lead Sponsor
University of Washington
Target Recruit Count
350
Registration Number
NCT06745050
Locations
πŸ‡°πŸ‡ͺ

Partner for Health and Development in Africa, Nairobi, Kenya

The Impact of an Evidence-Based Parenting Service on Maternal Sensitivity and Infant Cellular Aging in a Population of Under-Resourced Families

Not Applicable
Recruiting
Conditions
Parent Child Relationship
Child Social-Emotional Development
Telomere Length
Epigenetic Aging
First Posted Date
2024-12-18
Last Posted Date
2024-12-18
Lead Sponsor
University of Washington
Target Recruit Count
250
Registration Number
NCT06740266
Locations
πŸ‡ΊπŸ‡Έ

WakeMed Health & Hospitals, Raleigh, North Carolina, United States

Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

Phase 2
Not yet recruiting
Conditions
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
T Acute Lymphoblastic Leukemia
Interventions
Drug: Asparaginase Erwinia chrysanthemi
Procedure: Biospecimen Collection
Procedure: Bone Marrow Collection
Procedure: Computed Tomography
Drug: Cyclophosphamide
Drug: Doxorubicin
Drug: Etoposide
Biological: Filgrastim
Biological: Pegfilgrastim
Procedure: Positron Emission Tomography
Drug: Prednisone
Biological: Rituximab
Drug: Vincristine
First Posted Date
2024-12-17
Last Posted Date
2024-12-17
Lead Sponsor
University of Washington
Target Recruit Count
30
Registration Number
NCT06738368
Locations
πŸ‡ΊπŸ‡Έ

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Efficacy of Brief Interventions to Reduce Comorbid Alcohol and Cannabis Misuse and Sleep Impairment in Young Adults (Rest-Up RCT)

Not Applicable
Not yet recruiting
Conditions
Insomnia
Alcohol Use
Marijuana Use
First Posted Date
2024-12-16
Last Posted Date
2024-12-16
Lead Sponsor
University of Washington
Target Recruit Count
800
Registration Number
NCT06736444

Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.

Active, not recruiting
Conditions
Retinoblastoma Bilateral
Retinoblastoma Unilateral
Retinoblastoma, Extraocular
Retinoblastoma, Recurrent
Retinoblastoma
First Posted Date
2024-12-10
Last Posted Date
2024-12-10
Lead Sponsor
University of Washington
Target Recruit Count
100
Registration Number
NCT06725173
Locations
πŸ‡ΊπŸ‡Έ

University of Washington, Seattle, Washington, United States

Stroke and CPAP Outcome Study 3 Randomized Controlled Trial

Not Applicable
Not yet recruiting
Conditions
Stroke Patients
CPAP
OSA - Obstructive Sleep Apnea
First Posted Date
2024-12-09
Last Posted Date
2024-12-09
Lead Sponsor
University of Washington
Target Recruit Count
250
Registration Number
NCT06722755
Locations
πŸ‡ΊπŸ‡Έ

Rancho Research Institute, Downey, California, United States

πŸ‡ΊπŸ‡Έ

University of Washington - Harborview Medical Center, Seattle, Washington, United States

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

Not Applicable
Not yet recruiting
Conditions
Acute Myeloid Leukemia
B Acute Lymphoblastic Leukemia
B Lymphoblastic Lymphoma
Myeloid Neoplasm
First Posted Date
2024-11-28
Last Posted Date
2024-11-28
Lead Sponsor
University of Washington
Target Recruit Count
50
Registration Number
NCT06710418
Locations
πŸ‡ΊπŸ‡Έ

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Augmented Momentary Personal Ecological Risk Evaluation

Early Phase 1
Not yet recruiting
Conditions
Suicidal Ideation
Self Harm
First Posted Date
2024-11-26
Last Posted Date
2024-11-26
Lead Sponsor
University of Washington
Target Recruit Count
50
Registration Number
NCT06704958
Β© Copyright 2025. All Rights Reserved by MedPath